Drawing for CR CORREGENE

USPTO serial 79339666

CR CORREGENE

Reviewed by CopyMark Law Group

Reg. 7033281Status 700Registered
Filing date
Status date
Registration date
Apr 25, 2023
Examiner
GARCIA, CLAUDIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CR CORREGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC1540 WEST WARM SPRINGS ROAD SUITE 100HENDERSON, NV 89014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Enzyme preparations for medical purposes; surgical implants comprised of living tissues; Biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; stem cells for medical purposesACTIVE—
042Cosmetic research; chemical research; chemical analysis; medical laboratory services; medical research; biological research; bacteriological research; Medical and scientific research, namely, conducting clinical trials for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 4, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 4, 2023FIMPFINAL DISPOSITION PROCESSED—
Jul 25, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 25, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 25, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 7, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 18, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 18, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 18, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 5, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 5, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 5, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 5, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2022RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 24, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2022DOCKASSIGNED TO EXAMINER—
May 10, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 5, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance